Drug intelligence / Profile preview

h15H3-vcMMAE

Development stage
Preclinical
Lead developer
Skagen
Modality
Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

h15H3-vcMMAE is a preclinical antibody-drug conjugate (ADC) developed by Seattle Genetics (now Pfizer) that targets integrin β6 (ITGB6). The agent consists of a humanized monoclonal antibody, h15H3, conjugated to the microtubule-disrupting cytotoxin monomethyl auristatin E (MMAE) via a protease-cleavable valine-citrulline (vc) linker. Integrin β6 is an epithelial-specific integrin that is significantly upregulated in various solid tumors, including those of the pancreas, head and neck, lung, and bladder, while maintaining low expression in healthy tissues. Upon binding to the cell surface, the ADC is internalized and trafficked to lysosomes, where the linker is cleaved to release MMAE, leading to cell cycle arrest and apoptosis.

Other names
anti-integrin beta 6 ADC
02

Targets

αVβ6 (Integrin αVβ6)ITGB6 (Integrin beta-4)

Beyond the preview

Go deeper on h15H3-vcMMAE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on h15H3-vcMMAE.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call